Investing.com - Quoin Pharmaceuticals DRC reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Quoin Pharmaceuticals DRC announced earnings per share of $-0.94 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-1.39 on revenue of $0.00.
Quoin Pharmaceuticals DRC shares are down 4.96% from the beginning of the year and are trading at $1.92 , down-from-52-week-high.
Quoin Pharmaceuticals DRC shares gained 17.07% in intra-day trade the report.
Quoin Pharmaceuticals DRC follows other major Healthcare sector earnings this month
Quoin Pharmaceuticals DRC's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar